Paratransgenesis: Difference between revisions
Content deleted Content added
No edit summary |
tse-tse flies and malaria mosquitoes |
||
| Line 1: | Line 1: | ||
'''Paratransgenesis''' is a technique that attempts to eliminate a [[pathogen]] from [[Vector (epidemiology)|vector]] populations through [[transgenesis]] of a symbiont of the vector. The goal of this technique is to control vector-borne [[Disease|diseases]]. The first step is to identify [[Protein|proteins]] that prevent the vector species from transmitting the pathogen. The [[Gene|genes]] coding for these proteins are then introduced into the [[Symbiosis|symbiont]], so that they can be expressed in the vector. The final step in the strategy is to introduce these transgenic symbionts into vector populations in the wild. |
'''Paratransgenesis''' is a technique that attempts to eliminate a [[pathogen]] from [[Vector (epidemiology)|vector]] populations through [[transgenesis]] of a symbiont of the vector. The goal of this technique is to control vector-borne [[Disease|diseases]]. The first step is to identify [[Protein|proteins]] that prevent the vector species from transmitting the pathogen. The [[Gene|genes]] coding for these proteins are then introduced into the [[Symbiosis|symbiont]], so that they can be expressed in the vector. The final step in the strategy is to introduce these transgenic symbionts into vector populations in the wild. |
||
The first example of this technique used ''[[Rhodnius prolixus]]'' which is associated with the symbiont ''[[Rhodococcus rhodnii]]''. '' |
The first example of this technique used ''[[Rhodnius prolixus]]'' which is associated with the symbiont ''[[Rhodococcus rhodnii]]''. ''R. prolixus'' is an important insect vector of [[Chagas disease|Chagas's disease]] that is caused by ''[[Trypanosoma cruzi]]''. The strategy was to engineer ''R. rhodnii'' to express proteins such as Cecropin A that are toxic to ''T. cruzi'' or that block the transmission of ''T. cruzi''.<ref>Durvasula, R.V., Gumbs, A., Panackal, A., Kruglov, O., Aksoy, S., Merrifield, R.B., Richards, F.F., and Beard, C.B. (1997). Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proc. Natl. Acad. Sci. U. S. A. ''94'', 3274-3278.</ref> |
||
Attempts are also made in [[Tsetse fly|Tse-tse flies]] using bacteria<ref>{{cite journal|last=Aksoy|first=S|coauthors=Weiss, B; Attardo, G|title=Paratransgenesis applied for control of tsetse transmitted sleeping sickness.|journal=Advances in experimental medicine and biology|date=2008|volume=627|pages=35-48|pmid=18510012}}</ref><ref>{{cite journal|last=De Vooght|first=L|coauthors=Caljon, G; Stijlemans, B; De Baetselier, P; Coosemans, M; Van den Abbeele, J|title=Expression and extracellular release of a functional anti-trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the tsetse fly.|journal=Microbial cell factories|date=2012 Feb 15|volume=11|pages=23|pmid=22335892}}</ref> and in [[malaria|malaria mosquitoes]] using fungi<ref>{{cite journal|last=Fang|first=W|coauthors=Vega-Rodríguez, J; Ghosh, AK; Jacobs-Lorena, M; Kang, A; St Leger, RJ|title=Development of transgenic fungi that kill human malaria parasites in mosquitoes.|journal=Science (New York, N.Y.)|date=2011 Feb 25|volume=331|issue=6020|pages=1074-7|pmid=21350178}}</ref>, viruses<ref>{{cite journal|last=Ren|first=X|coauthors=Hoiczyk, E; Rasgon, JL|title=Viral paratransgenesis in the malaria vector Anopheles gambiae.|journal=PLoS pathogens|date=2008 Aug 22|volume=4|issue=8|pages=e1000135|pmid=18725926}}</ref>, or bacteria<ref>{{cite journal|last=Rodrigues|first=FG|coauthors=Santos, MN; de Carvalho, TX; Rocha, BC; Riehle, MA; Pimenta, PF; Abraham, EG; Jacobs-Lorena, M; Alves de Brito, CF; Moreira, LA|title=Expression of a mutated phospholipase A2 in transgenic Aedes fluviatilis mosquitoes impacts Plasmodium gallinaceum development.|journal=Insect molecular biology|date=2008 Apr|volume=17|issue=2|pages=175-83|pmid=18353106}}</ref>. |
|||
In order to perform paratransgenesis, there are several requirements: |
In order to perform paratransgenesis, there are several requirements: |
||
Revision as of 14:29, 20 February 2013
Paratransgenesis is a technique that attempts to eliminate a pathogen from vector populations through transgenesis of a symbiont of the vector. The goal of this technique is to control vector-borne diseases. The first step is to identify proteins that prevent the vector species from transmitting the pathogen. The genes coding for these proteins are then introduced into the symbiont, so that they can be expressed in the vector. The final step in the strategy is to introduce these transgenic symbionts into vector populations in the wild.
The first example of this technique used Rhodnius prolixus which is associated with the symbiont Rhodococcus rhodnii. R. prolixus is an important insect vector of Chagas's disease that is caused by Trypanosoma cruzi. The strategy was to engineer R. rhodnii to express proteins such as Cecropin A that are toxic to T. cruzi or that block the transmission of T. cruzi.[1]
Attempts are also made in Tse-tse flies using bacteria[2][3] and in malaria mosquitoes using fungi[4], viruses[5], or bacteria[6].
In order to perform paratransgenesis, there are several requirements:
- The Symbiotic bacteria can be grown in vitro easily.
- They can be genetically modified, such as through transformation with a plasmid containing the desired gene.
- The engineered symbiont is stable and safe.
- The association between vector and symbiont cannot be attenuated.
- Field delivery is easily handled.
References
- ^ Durvasula, R.V., Gumbs, A., Panackal, A., Kruglov, O., Aksoy, S., Merrifield, R.B., Richards, F.F., and Beard, C.B. (1997). Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proc. Natl. Acad. Sci. U. S. A. 94, 3274-3278.
- ^ Aksoy, S (2008). "Paratransgenesis applied for control of tsetse transmitted sleeping sickness". Advances in experimental medicine and biology. 627: 35–48. PMID 18510012.
{{cite journal}}: Unknown parameter|coauthors=ignored (|author=suggested) (help) - ^ De Vooght, L (2012 Feb 15). "Expression and extracellular release of a functional anti-trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the tsetse fly". Microbial cell factories. 11: 23. PMID 22335892.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help) - ^ Fang, W (2011 Feb 25). "Development of transgenic fungi that kill human malaria parasites in mosquitoes". Science (New York, N.Y.). 331 (6020): 1074–7. PMID 21350178.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help) - ^ Ren, X (2008 Aug 22). "Viral paratransgenesis in the malaria vector Anopheles gambiae". PLoS pathogens. 4 (8): e1000135. PMID 18725926.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help) - ^ Rodrigues, FG (2008 Apr). "Expression of a mutated phospholipase A2 in transgenic Aedes fluviatilis mosquitoes impacts Plasmodium gallinaceum development". Insect molecular biology. 17 (2): 175–83. PMID 18353106.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help)